Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Bayer
Bayer
Bayer's hot-selling Eylea runs into a roadblock in its home market
Fierce Pharma
Sat, 01/4/14 - 04:32 pm
Eylea
Bayer
Novartis
macular edema
Lucentis
Germany
Bright Prospects at Bayer
Yahoo/Zacks.com
Fri, 01/3/14 - 11:53 am
Bayer
Xarelto
Eylea
Stivarga
Adempas
Lemtrada
Xofigo
Buzz: Buyer in talks to acquire big stake in Celltrion
Fierce Biotech
Thu, 01/2/14 - 11:32 am
Bayer
M&A
Celltrion
Bayer executive sees benefits of R&D changes as early as 2016
Reuters
Thu, 01/2/14 - 09:50 am
R&D
Bayer
Pfizer's Expiring Viagra Patent Adversely Affects Other Drugmakers Too
Forbes
Sat, 12/21/13 - 11:45 am
Pfizer
Viagra
Eli Lilly
erectile dysfunction
Bayer
Levitra
Cialis
Bayer wins Norway cancer firm Algeta with raised $2.9 billion offer
Reuters
Thu, 12/19/13 - 11:30 am
Algeta
Bayer
M&A
Novartis opens animal health books to Bayer, others - sources
Yahoo/Reuters
Tue, 12/3/13 - 09:29 am
Novartis
animal health
Bayer
M&A
Bayer bids $2.4 billion for Norwegian cancer drug partner Algeta
Yahoo/Reuters
Tue, 11/26/13 - 08:48 am
Bayer
M&A
Algeta
Drug developer Compugen sees boost from Bayer oncology deal
Yahoo/Reuters
Mon, 11/25/13 - 10:41 am
Bayer
CompuGen
oncology
U.S. FDA Approves NEXAVAR (sorafenib) for the Treatment of Patients with Locally Recurrent or Metastatic, Progressive, Differentiated Thyroid Carcinoma Refractory to Radioactive Iodine Treatment
Yahoo/PR NewsWire
Sat, 11/23/13 - 12:06 pm
Nexavar
Bayer
ONYX Pharmaceuticals
Amgen
thyroid cancer
refractory differential thyroid cancer
Bayer receives new approval for Eylea eye treatment in Japan
Yahoo/Reuters
Fri, 11/22/13 - 08:29 am
Bayer
Japan
Eylea
macular edema
A Few Dozen Here, A Few Dozen There... More Pharma Layoffs
Pharmalot
Wed, 11/20/13 - 12:10 pm
layoffs
Actavis
AstraZeneca
Bayer
Analyst ranks the top 11 pharma giants' prospects, putting GSK on top
Fierce Biotech
Wed, 11/6/13 - 10:39 am
GSK
Bayer
Sanofi
Novartis
JNJ
Bristol-Myers Squibb
Merck
AbbVie
Eli Lilly
Pfizer
AstraZeneca
Bayer Third-Quarter Earnings Rise on New Medicines
Bloomberg
Thu, 10/31/13 - 11:33 am
earnings
Bayer
Actelion’s Drug Approval Seen Enticing Buyers: Real M&A
Bloomberg
Mon, 10/28/13 - 08:32 am
M&A
Actelion
Opsumit
Bayer
The real Erin Brockovich takes on Bayer's birth control
Mass Device
Thu, 10/17/13 - 09:58 am
Essure
Bayer
contraceptives
devices
Former Bayer Employee Can Proceed With Whistleblower Lawsuit
Pharmalot
Wed, 10/16/13 - 11:03 am
Bayer
Baycol
whistleblower lawsuits
Top 10 Drugmakers in Emerging Markets
Fierce Pharma
Mon, 10/14/13 - 10:31 am
emerging markets
Bayer
Sanofi
Merck KGaA
GSK
Novartis
JNJ
Novo Nordisk
AstraZeneca
Pfizer
Roche
Bayer wins key FDA approval for lung disease drug Adempas
Fierce Biotech
Wed, 10/9/13 - 10:13 am
Adempas
Bayer
FDA
Riociguat
thromboembolic pulmonary hypertension
Bayer to bring five mid-stage drugs into Phase III by 2015
Reuters
Tue, 10/8/13 - 08:36 am
Bayer
oncology
cardiology
Women's Health
Pages
« first
‹ previous
…
28
29
30
31
32
33
34
35
36
…
next ›
last »